Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives.

Awe JP, Gschweng EH, Vega-Crespo A, Voutila J, Williamson MH, Truong B, Kohn DB, Kasahara N, Byrne JA.

Stem Cells Transl Med. 2015 Feb;4(2):136-45. doi: 10.5966/sctm.2014-0117. Epub 2015 Jan 9.

PMID:
25575527
[PubMed - in process]
2.

Derivation and characterization of a transgene-free human induced pluripotent stem cell line and conversion into defined clinical-grade conditions.

Awe JP, Vega-Crespo A, Byrne JA.

J Vis Exp. 2014 Nov 26;(93):e52158. doi: 10.3791/52158.

PMID:
25490111
[PubMed - in process]
3.

Overexpressed oncogenic tumor-self antigens.

Bright RK, Bright JD, Byrne JA.

Hum Vaccin Immunother. 2014 Nov 2;10(11):3297-305. doi: 10.4161/hv.29475.

PMID:
25483660
[PubMed - in process]
4.

Developing neural stem cell-based treatments for neurodegenerative diseases.

Byrne JA.

Stem Cell Res Ther. 2014 May 30;5(3):72. doi: 10.1186/scrt461.

PMID:
25157920
[PubMed - in process]
5.

Overexpressed oncogenic tumor-self antigens: New vaccine targets.

Bright RK, Bright JD, Byrne JA.

Hum Vaccin Immunother. 2014 Jul 7;10(11). [Epub ahead of print] Review.

PMID:
25000407
[PubMed - as supplied by publisher]
6.

Informal urban green-space: comparison of quantity and characteristics in Brisbane, Australia and Sapporo, Japan.

Rupprecht CD, Byrne JA.

PLoS One. 2014 Jun 18;9(6):e99784. doi: 10.1371/journal.pone.0099784. eCollection 2014.

PMID:
24941046
[PubMed - in process]
Free PMC Article
7.

Investigation of the inhibitory effects of TiO(2) on the β-amyloid peptide aggregation.

Ahmed MH, Byrne JA, Keyes TE.

Mater Sci Eng C Mater Biol Appl. 2014 Jun 1;39:227-34. doi: 10.1016/j.msec.2014.03.011. Epub 2014 Mar 12.

PMID:
24863220
[PubMed - indexed for MEDLINE]
8.

Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

Byrne JA, Frost S, Chen Y, Bright RK.

Tumour Biol. 2014 Aug;35(8):7369-82. doi: 10.1007/s13277-014-2006-x. Epub 2014 May 6. Review.

PMID:
24798974
[PubMed - indexed for MEDLINE]
9.

Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening.

Shahheydari H, Frost S, Smith BJ, Groblewski GE, Chen Y, Byrne JA.

Mol Biol Rep. 2014 Jul;41(7):4565-72. doi: 10.1007/s11033-014-3327-y. Epub 2014 Mar 7.

PMID:
24604726
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Color me healthy: food diversity in school community gardens in two rapidly urbanising Australian cities.

Guitart DA, Pickering CM, Byrne JA.

Health Place. 2014 Mar;26:110-7. doi: 10.1016/j.healthplace.2013.12.014. Epub 2013 Dec 31.

PMID:
24434081
[PubMed - in process]
11.

Proteomic screening of glutamatergic mouse brain synaptosomes isolated by fluorescence activated sorting.

Biesemann C, Grønborg M, Luquet E, Wichert SP, Bernard V, Bungers SR, Cooper B, Varoqueaux F, Li L, Byrne JA, Urlaub H, Jahn O, Brose N, Herzog E.

EMBO J. 2014 Jan 13;33(2):157-70. doi: 10.1002/embj.201386120. Epub 2014 Jan 10.

PMID:
24413018
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Germline stem cells: toward the regeneration of spermatogenesis.

Valli H, Phillips BT, Shetty G, Byrne JA, Clark AT, Meistrich ML, Orwig KE.

Fertil Steril. 2014 Jan;101(1):3-13. doi: 10.1016/j.fertnstert.2013.10.052. Epub 2013 Dec 5. Review.

PMID:
24314923
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen.

Bright JD, Schultz HN, Byrne JA, Bright RK.

Oncoimmunology. 2013 Jul 1;2(7):e25049. Epub 2013 May 21.

PMID:
24073379
[PubMed]
Free PMC Article
14.

Tumor protein D52 represents a negative regulator of ATM protein levels.

Chen Y, Kamili A, Hardy JR, Groblewski GE, Khanna KK, Byrne JA.

Cell Cycle. 2013 Sep 15;12(18):3083-97. doi: 10.4161/cc.26146. Epub 2013 Aug 21.

PMID:
23974097
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The association between TNF-α and insulin resistance in euglycemic women.

Walsh JM, McGowan CA, Byrne JA, Rath A, McAuliffe FM.

Cytokine. 2013 Oct;64(1):208-12. doi: 10.1016/j.cyto.2013.07.001. Epub 2013 Aug 14.

PMID:
23953853
[PubMed - indexed for MEDLINE]
16.

Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.

Kasten J, Hu C, Bhargava R, Park H, Tai D, Byrne JA, Marescau B, De Deyn PP, Schlichting L, Grody WW, Cederbaum SD, Lipshutz GS.

Mol Genet Metab. 2013 Nov;110(3):222-30. doi: 10.1016/j.ymgme.2013.06.020. Epub 2013 Jul 6.

PMID:
23920045
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.

Awe JP, Lee PC, Ramathal C, Vega-Crespo A, Durruthy-Durruthy J, Cooper A, Karumbayaram S, Lowry WE, Clark AT, Zack JA, Sebastiano V, Kohn DB, Pyle AD, Martin MG, Lipshutz GS, Phelps PE, Pera RA, Byrne JA.

Stem Cell Res Ther. 2013 Jul 26;4(4):87. doi: 10.1186/scrt246.

PMID:
23890092
[PubMed - in process]
Free PMC Article
18.

Tumor protein D52 controls trafficking of an apical endolysosomal secretory pathway in pancreatic acinar cells.

Messenger SW, Thomas DD, Falkowski MA, Byrne JA, Gorelick FS, Groblewski GE.

Am J Physiol Gastrointest Liver Physiol. 2013 Sep 15;305(6):G439-52. doi: 10.1152/ajpgi.00143.2013. Epub 2013 Jul 18.

PMID:
23868405
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

TPD52 represents a survival factor in ERBB2-amplified breast cancer cells.

Roslan N, Bièche I, Bright RK, Lidereau R, Chen Y, Byrne JA.

Mol Carcinog. 2014 Oct;53(10):807-19. doi: 10.1002/mc.22038. Epub 2013 May 9.

PMID:
23661506
[PubMed - indexed for MEDLINE]
20.

Identifying candidate oocyte reprogramming factors using cross-species global transcriptional analysis.

Awe JP, Byrne JA.

Cell Reprogram. 2013 Apr;15(2):126-33. doi: 10.1089/cell.2012.0060. Epub 2013 Mar 4.

PMID:
23458164
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk